Benzinga | Dec 10, 2021 04:59AM EST

RBC Capital Initiates Coverage On Abbott Laboratories with Outperform Rating, Announces Price Target of $146

RBC Capital analyst Shagun Singh initiates coverage on Abbott Laboratories (NYSE:ABT) with a Outperform rating and announces Price Target of $146.